摘要
直肠癌新辅助治疗后等待观察策略(W&W)作为新兴的治疗方法,目前并非直肠癌患者标准治疗方案,但已被部分指南接受。开展W&W的法律风险在于,一旦医疗行为未达到预期效果,患方可能认为是由于医方治疗方案的选择错误,延误其接受直肠癌根治性切除术,从而引发医疗争议。对于上述法律风险,开展直肠癌新辅助治疗后W&W策略时,医务人员应尽到更高的责任义务,包括确认该治疗方法具备相对可靠的循证医学证据、充分履行告知义务并取得患方知情同意、制定标准化的诊疗程序以确保诊疗行为的规范性。同时,通过患者教育及沟通,使患者知悉、配合医务人员为改善患者结局及生活质量所做的努力,了解接受此治疗策略可能的获益及风险,以及接受常规治疗的疗效及损害,以共同做出治疗选择。
As an emerging treatment method,watch and wait(W&W)strategy is not the standard treatment for rectal cancer patients but recommended by some guidelines.The legal risk of W&W is that once the medical behavior fails to achieve the desired effect,the patient may think that it is because of the wrong choice of treatment plan and delay of radical resection,thus causing medical dispute.As for the above legal risks,medical personnel should fulfill higher obligations when carrying out W&W strategy after neoadjuvant treatment for rectal cancer,including confirming that the treatment method has relatively reliable evidence-based medical evidence,fully implementing the information obligation and obtaining informed consent of the patient,and formulating standardized treatment procedures to ensure the standardization of medical behavior.At the same time,through patient education and communication,patients are aware of and coordinate with the efforts made by medical staff to improve patients'outcomes and quality of life,so as to understand the possible benefits and risks of this treatment strategy,as well as the efficacy and damage of complying with conventional treatment,and make final decision together with the medical staff.
出处
《中华胃肠外科杂志》
CAS
CSCD
北大核心
2020年第3期220-224,共5页
Chinese Journal of Gastrointestinal Surgery
关键词
直肠肿瘤
新辅助治疗
临床完全缓解
等待观察策略
患者保护
Rectal neoplasms
Neoadjuvant therapy
Clinical complete response
Watch and wait strategy
Patient protection
